Update Breast Cancer 2023 Part 1 – Early Stage Breast Cancer
Geburtshilfe und Frauenheilkunde · 01.06.2023 · 83 (06) · 653-663
DOI: 10.1055/a-2074-0551 ↗Kurz gefasst
Fachartikel in der Zeitschrift Geburtshilfe und Frauenheilkunde, erschienen am 01.06.2023. Verfasst von Andreas D Hartkopf und 29 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology and Obstetrics, Ulm University Hospital, Ulm, Germany. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
With abemaciclib (monarchE study) and olaparib (OlympiA study) gaining approval in the adjuvant treatment setting, a significant change in the standard of care for patients with early stage breast cancer has been established for some time now. Accordingly, some diverse developments are slowly being transferred from the metastatic to the adjuvant treatment setting. Recently, there have also been positive reports of the NATALEE study. Other clinical studies are currently investigating substances that are already established in the metastatic setting. These include, for example, the DESTINY Breast05 study with trastuzumab deruxtecan and the SASCIA study with sacituzumab govitecan. In this review paper, we summarize and place in context the latest developments over the past months.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gynecology and Obstetrics, Ulm University Hospital, Ulm, Germany.
- Department of Gynecology and Obstetrics, University Hospital Düsseldorf, Düsseldorf, Germany.
- Onkologie Aschaffenburg, Aschaffenburg, Germany.
- Department of Gynecology, Hamburg-Eppendorf University Medical Center, Hamburg, Germany.
- Gynäkologie und Geburtshilfe, Diakonissen-Stiftungs-Krankenhaus Speyer, Speyer, Germany.
- Erlangen University Hospital, Department of Gynecology and Obstetrics; Comprehensive Cancer Center Erlangen EMN, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany.
Zitieren
APA
Hartkopf, A. D., Fehm, T. N., Welslau, M., Müller, V., Schütz, F., Fasching, P. A., Janni, W., Witzel, I., Thomssen, C., Beierlein, M., Belleville, E., Untch, M., Thill, M., Tesch, H., Ditsch, N., Lux, M. P., Aktas, B., Banys-Paluchowski, M., Kolberg-Liedtke, C., …, & Lüftner, D. (2023). Update Breast Cancer 2023 Part 1 – Early Stage Breast Cancer. Geburtshilfe und Frauenheilkunde, 83(06), 653-663. https://doi.org/10.1055/a-2074-0551
Vancouver
Hartkopf AD, Fehm TN, Welslau M, Müller V, Schütz F, Fasching PA, et al. Update Breast Cancer 2023 Part 1 – Early Stage Breast Cancer. Geburtshilfe und Frauenheilkunde. 2023;83(06):653-663. doi:10.1055/a-2074-0551
BibTeX
@article{Hartkopf2023,
author = {Hartkopf, Andreas D and Fehm, Tanja N and Welslau, Manfred and Müller, Volkmar and Schütz, Florian and Fasching, Peter A and Janni, Wolfgang and Witzel, Isabell and Thomssen, Christoph and Beierlein, Milena and Belleville, Erik and Untch, Michael and Thill, Marc and Tesch, Hans and Ditsch, Nina and Lux, Michael P and Aktas, Bahriye and Banys-Paluchowski, Maggie and Kolberg-Liedtke, Cornelia and Wöckel, Achim and Kolberg, Hans-Christian and Harbeck, Nadia and Stickeler, Elmar and Bartsch, Rupert and Schneeweiss, Andreas and Ettl, Johannes and Würstlein, Rachel and Krug, David and Taran, Florin-Andrei and Lüftner, Diana},
title = {Update Breast Cancer 2023 Part 1 – Early Stage Breast Cancer},
journal = {Geburtshilfe und Frauenheilkunde},
year = {2023},
volume = {83},
number = {06},
pages = {653--663},
doi = {10.1055/a-2074-0551}
}
EUVIMED